ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,440.00
2.13%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36715
0.03%
Bitcoin
62,596.24
5.88%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Collegium Pharmaceutical Inc (COLL)

  7. Collegium Pharmaceutical Inc (COLL) News

COLL Collegium Pharmaceutical Inc

37.475
-0.035 (-0.09%)
After Hours
Last Updated: 16:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Collegium Pharmaceutical Inc COLL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.035 -0.09% 37.475 16:00:00
Open Price Low Price High Price Close Price Previous Close
37.80 37.29 38.32 37.475 37.51
more quote information »

Recent News

Date Time Source Heading
4/29/202407:00GLOBECollegium Announces Authorized Generic Agreement with Hikma..
4/25/202407:00GLOBECollegium to Report First Quarter 2024 Financial Results on..
4/11/202407:00GLOBECollegium Pharmaceutical, Inc. Announces Redemption of..
4/03/202407:00GLOBECollegium to Participate in 23rd Annual Needham Virtual..
3/04/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:24EDGAR2Form 144 - Report of proposed sale of securities
2/26/202415:39EDGAR2Form 144 - Report of proposed sale of securities
2/22/202415:09GLOBECollegium Reports Record Fourth Quarter and Full-Year 2023..
2/22/202415:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/22/202415:01EDGAR2Form 8-K - Current report
2/14/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202411:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202407:00GLOBECollegium to Report Fourth Quarter and Full-Year 2023..
1/18/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/16/202415:20EDGAR2Form 144 - Report of proposed sale of securities
1/03/202407:03EDGAR2Form 8-K - Current report
1/03/202407:00GLOBECollegium Provides 2024 Financial Guidance
12/22/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202315:15EDGAR2Form 144 - Report of proposed sale of securities
12/20/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202315:28EDGAR2Form 144 - Report of proposed sale of securities
12/19/202315:13EDGAR2Form 144 - Report of proposed sale of securities
12/18/202315:11EDGAR2Form 144 - Report of proposed sale of securities
11/29/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/27/202316:00EDGAR2Form 144 - Report of proposed sale of securities
11/27/202307:00GLOBEAppeals Court Upholds PTAB’s Finding of Invalidity of..
11/09/202307:05EDGAR2Form 8-K - Current report
11/09/202307:00GLOBECollegium Announces $25 Million Accelerated Share Repurchase..
11/08/202307:00GLOBECollegium to Participate in Upcoming Investor Conferences
11/07/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202315:01EDGAR2Form 8-K - Current report
11/07/202315:01GLOBECollegium Reports Third Quarter 2023 Financial Results
10/24/202307:00GLOBECollegium to Report Third Quarter 2023 Financial Results on..
8/28/202307:00GLOBECollegium Announces 10 Poster Presentations at PAINWeek..
8/24/202307:05EDGAR2Form 8-K - Current report
8/24/202307:00GLOBECollegium Announces Extension of Nucynta Regulatory..
8/10/202315:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/07/202306:40EDGAR2Form 8-K - Current report
8/07/202306:30GLOBECollegium Announces $50 Million Accelerated Share Repurchase..
8/03/202315:03EDGAR2Form 8-K - Current report
8/03/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202315:01GLOBECollegium Reports Record 1H’23 Net Revenue of $280.3..
7/20/202307:00GLOBECollegium to Report Second Quarter 2023 Financial Results on..
6/28/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/01/202307:00GLOBECollegium to Participate in Jefferies Healthcare Conference
5/04/202315:01GLOBECollegium Reports First Quarter 2023 Financial Results

Your Recent History

NASDAQ
COLL
Collegium Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved